ADAR1 Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $443K | Buy |
29,625
+1,700
| +6% | +$25.4K | 0.07% | 118 |
|
|
2025
Q1 | $327K | Buy |
+27,925
| New | +$327K | 0.06% | 119 |
|
|
2024
Q4 | – | Sell |
-553
| Closed | -$23.2K | – | 258 |
|
|
2024
Q3 | $23.2K | Sell |
553
-700
| -56% | -$29.4K | ﹤0.01% | 224 |
|
|
2024
Q2 | $45.6K | Buy |
1,253
+592
| +90% | +$21.5K | 0.01% | 180 |
|
|
2024
Q1 | $33.6K | Sell |
661
-4,744
| -88% | -$241K | 0.01% | 182 |
|
|
2023
Q4 | $105K | Buy |
+5,405
| New | +$105K | 0.04% | 83 |
|